Skip to main content
. 2018 Jul 10;8:239. doi: 10.3389/fcimb.2018.00239

Figure 4.

Figure 4

Vaccine potential of JEV E-glycosylation mutants. Four-week-old C57BL/6 mice (n = 4 per group) were subcutaneously injected with JEV E-glycosylation mutants at 101, 102, or 103 PFU per mouse. Two weeks after immunization, mice were challenged with 2 × 105 PFU of the JEV WT RP-9 strain by the ip plus ic route. Mouse survival was observed daily. Prism software with the log rank test was used to compare survival curves. *P < 0.05.